It has been reported that CSN-specific phosphorylation of TP53 dedicates the protein to rapid degradation by the ubiquitin-26S proteasome system (Bech-Otschir et al. 2001), and thus we hypothesized that GPS1 could contribute to breast cancer development by affecting the stability and mutational status of TP53. This evidence concerns the gene GPS1 and breast carcinoma.